Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Howard Marks Recollects His $3 Billion Bet From 2008 Financial Crisis—He Believes We're In 'Early Days' Of Market Bubble
Via Benzinga
Topics Product Recall
Tickers QQQ SPY
Exposures Legal Product Safety
Alex Karp Wanted $250K While Building Palantir With Peter Thiel—Now Worth $14 Billion, PLTR CEO Recalls How Dyslexia Taught Him To Reject Conformity
Via Benzinga
Topics Product Recall
Tickers PLTR
Exposures Legal Product Safety
Author Cynthia Lauri Reflects on Her Struggles with Weight and Self Image in New Memoir
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Hana Dhanji Champions a New Era of Leadership: Alignment, Purpose, and Sustainable Success
Via Get News
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
Via Stocktwits
Tickers AQST IWMW VTWG
Exposures Product Safety
Zhenneng-Stainless Steel Kitchenware Manufacturer for Major World-Renowned Kitchenware Brands
Via Get News
Topics Supply Chain
Exposures Product Safety Supply Chain
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals
Via Benzinga
Tickers LXEO NGNE QURE RARE RCKT
Exposures Product Safety
Biogen (BIIB) Stock Trades Down, Here Is Why
Via StockStory
Topics Artificial Intelligence
Tickers AAPL BIIB MSFT
Exposures Artificial Intelligence Product Safety
FDA Breakthrough Status Awarded To Lilly-Merck Combo Drug For Advanced Non-Small Cell Lung Cancer
Via Benzinga
Tickers LLY MRK
Exposures Product Safety
IBORRIA Expands At-Home Beauty Portfolio with Advanced LED, RF, and IPL Technologies
Via Get News
Exposures Product Safety
FDA Confirms Direct Review Path For Aquestive's Allergy Treatment
Via Benzinga
Tickers AQST
Exposures Product Safety
Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More
Via Stocktwits
Tickers AGIO IWMW VFMO
Exposures Product Safety
Author’s Tranquility Press Announces the Release of Americans the Beautiful: An Italian American Memoir by Philip Caravella
Via AB Newswire
Topics Bonds Product Recall
Tickers AMZN
Exposures Debt Markets Legal Product Safety
FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use
Via Benzinga
Tickers AGIO
Exposures Product Safety
Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Treatment with FDA Orphan Designation
Via Investor Brand Network
Tickers BMWYY SNGX
Exposures Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Shareholders of Capricor Therapeutics, Inc. Should Contact Levi &amp; Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Shareholders of Capricor Therapeutics, Inc. Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Rockin Resources Announces Upcoming Writing Guide Release
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial
Via Investor Brand Network
Topics Artificial Intelligence
Tickers LTRN
Exposures Artificial Intelligence Product Safety
After Copycat Boom, China's Drugmakers Target Global Generics
Via Benzinga
Topics Supply Chain
Tickers LLY NVO
Exposures Product Safety Supply Chain
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Class Action Filed Against Replimune Group, Inc. (REPL) - September 22, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Class Action Filed Against Replimune Group, Inc. (REPL) - September 22, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.